Chongqing Genrix Biopharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Chongqing Genrix Biopharmaceutical has a total shareholder equity of CN¥2.7B and total debt of CN¥620.6M, which brings its debt-to-equity ratio to 23.3%. Its total assets and total liabilities are CN¥3.5B and CN¥792.6M respectively.
Key information
23.3%
Debt to equity ratio
CN¥620.62m
Debt
Interest coverage ratio | n/a |
Cash | CN¥2.76b |
Equity | CN¥2.66b |
Total liabilities | CN¥792.60m |
Total assets | CN¥3.45b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688443's short term assets (CN¥2.9B) exceed its short term liabilities (CN¥120.1M).
Long Term Liabilities: 688443's short term assets (CN¥2.9B) exceed its long term liabilities (CN¥672.6M).
Debt to Equity History and Analysis
Debt Level: 688443 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 688443's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 688443 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 688443 has sufficient cash runway for 2.6 years if free cash flow continues to reduce at historical rates of 16.9% each year.